Results 11 to 20 of about 1,552,446 (340)

Voclosporin and the Antiviral Effect Against SARS-CoV-2 in Immunocompromised Kidney Patients

open access: yesKidney International Reports, 2023
Introduction: Immunocompromised kidney patients are at increased risk of prolonged SARS-CoV-2 infection and related complications. Preclinical evidence demonstrates a more potent inhibitory effect of voclosporin on SARS-CoV-2 replication than tacrolimus ...
Eline J. Arends   +14 more
doaj   +1 more source

Bartonella and Coxiella infections presenting as systemic vasculitis: case series and review of literature.

open access: yesRheumatology, 2021
OBJECTIVES Coxiella and Bartonella sp. display particular tropism for endothelial or endocardial tissues and an abnormal host response to infections with induced autoimmunity.
M. Beydon   +14 more
semanticscholar   +1 more source

Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial

open access: yesTrials, 2022
Background Belimumab, an anti-B-cell activating factor antibody, is approved for the treatment of auto-antibody positive systemic lupus erythematosus with a high degree of disease activity.
Mieke van Schaik   +12 more
doaj   +1 more source

Systemic Vasculitis

open access: yesThe International Journal of Lower Extremity Wounds, 2002
The systemic vasculitides are a heterogeneous group of disorders characterized by inflammation of blood vessel walls. They can be classified according to the size of vessel affected and also into primary de novo vasculitides and secondary to other disease processes. Treatments differ and overlap depending on the type of vasculitis.
Jordan, Kelsey M., Cooper, Cyrus
openaire   +4 more sources

Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients

open access: yesFrontiers in Immunology, 2020
BackgroundB-cell depletion with rituximab (RTX) is an effective treatment for anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) patients.
Laura S. van Dam   +9 more
doaj   +1 more source

A sore red eye with systemic involvement [PDF]

open access: yes, 2010
The study of happiness has long been a playground for philosophical speculation. By lack of empirical measures of happiness, it was not possible to check propositions about the matter.
Lightman, SL   +3 more
core   +2 more sources

2020 international consensus on ANCA testing beyond systemic vasculitis.

open access: yesAutoimmunity Reviews, 2020
This document follows up on a 2017 revised international consensus on anti-neutrophil cytoplasm antibodies (ANCA) testing in granulomatosis with polyangiitis and microscopic polyangiitis and focuses on the clinical and diagnostic value of ANCA detection ...
S. Moiseev   +29 more
semanticscholar   +1 more source

The Impact of High Dose Glucocorticoids on Bone Health and Fracture Risk in Systemic Vasculitides

open access: yesFrontiers in Endocrinology, 2022
Systemic vasculitides are a range of conditions characterized by inflammation of blood vessels which may manifest as single organ or life-threatening multisystem disease.
Christopher David Box   +4 more
doaj   +1 more source

Vasculitic peripheral neuropathy [PDF]

open access: yesReviews in Clinical Medicine, 2014
Primary systemic vasculitis in pre-capillary arteries is associated with peripheral neuropathy. In some types of systematic vasculitis about 60 % of patients have peripheral nervous system (PNS) involvement.
Mona Amini   +2 more
doaj   +3 more sources

Classification of systemic vasculitis: evolution from eponyms to modern criteria

open access: yesТерапевтический архив, 2022
Systemic vasculitis is a manifold group of systemic autoimmune diseases characterized by the inflammation of the blood vessels. The first clinical cases of systemic vasculitis were described in the Middle Ages, and most of the currently recognised ...
Nikolay M. Bulanov   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy